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Abstract
Background: Osteoarthritis (OA) involves cartilage changes as well as modifications of subchondral bone and
synovial tissues. Strontium ranelate (SR), an anti-osteoporosis compound, which is currently in phase III clinical trial
for treatment of OA. Evidences suggest that SR preferably deposited in osteophyte, other than in subchondral bone
in early phase of OA. This phenomenon raises concern about its utility for OA treatment as a disease-modifying
drug. To evaluate the effect of SR on cartilage, subchondral bone mass and subchondral trabecular bone structure
in medial meniscectomized (MNX) guinea pigs.
Method: Thirty-six 3-month-old male Dunkin Hartley albino guinea pigs received either sham or medial meniscectomy
operations. One week after the procedure, meniscectomized animals began 12 weeks of SR (625 mg/kg, daily) treatment
by oral gavage for MNX + SR group, or normal saline for MNX + V group. All animals were euthanized 12 weeks later,
cartilage degeneration and subchondral bone micro-architecture was analyzed.
Results: Both OARSI scores (P = 0.523 for marcoscopic scores, P = 0.297 for histological scores) and Cartilage thickness
(P = 0.335) in MNX + SR group were comparable to MNX + V group. However, osteophyte sizes were larger in MNX +
SR group (P = 0.014), and collapsed osteophytes in MNX + SR group (7 by 12) were significantly more than in MNX +
V group (1 by 12) (P = 0.027), while immunohistochemistry indicates catabolic changes in osteophyte/plateau junction.
Micro-CT analysis showed bone mineral density (BMD) (P = 0.001), bone volume fraction (BV/TV) (P = 0.008), trabecular
spacing (Tb.Sp) (P = 0.020), trabecular thickness (Tb.Th) (P = 0.012) and structure model index (SMI) (P = 0.005) levels to
be significantly higher in the MNX + SR group than in the MNX + V group.
Conclusions: SR (625 mg/kg/day) did not protect cartilage from degeneration in MNX guinea pigs but
subchondral bone was significantly enhanced. In early phase OA, SR administration causes osteophyte
overgrowth, which may be related to incorporation into mineralizing osteophytes. This adverse effect is
important for future studies of SR in OA.
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Background
Osteoarthritis (OA) involves cartilage changes as well as
modifications of subchondral bone and synovial tissues.
Evidence suggest that subchondral bone mass is reduced
in early progression of OA [1, 2]. In contrast, some anti-
resorptive drugs, such as bisphosphonates [3] and
PTH(1-34) [4], were found to protect cartilage from OA
progression, so various bone metabolism regulators were
considered for potential disease-modifying OA drugs
and many are under evaluation [5–7].
Strontium ranelate (SR) an anti-osteoporosis com-
pound that protects postmenopausal women from ver-
tebral and non-vertebral fractures [8], it is currently in
phase III clinical trial for treatment of OA [9]. It con-
tains strontium element (Sr) which is similar to calcium
in that it can be incorporated into bone and/or stimu-
late calcium-sensing receptors in bone cells [10]. In
vitro data show that SR stimulates OPG and inhibits
RANKL synthesis in osteoblasts [11]. Several clinical
studies indicated that OA patients would benefit from
SR treatment. SR has been shown to reduce a urinary
cartilage degradation biomarker, CTX-II, in postmeno-
pausal women [12]. Another double-blind, randomized,
placebo-controlled trial confirmed that SR 2 g/day is as-
sociated improvements in Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) scores as
evidenced by radiographic data [13]. Another trial indicates
treatment with strontium ranelate 2 g/day over 3 years is
associated with a clinically meaningful improvement in
pain from 6 months after treatment initiated [14]. Animal
models are also underway to investigate the mechanism of
SR in OA, which have shown therapeutic effects [15–17].
However, several recent studies [6, 18] showed evi-
dences that SR preferably deposited in osteophyte, other
than in subchondral bone. This phenomenon raises con-
cern about its utility for OA treatment as a disease-
modifying drug, which also prompts that it still needs to
study on the effect of SR on OA joints. Thus we studied
the effect of SR in a meniscectomized (MNX) guinea pig
model, however, found a potential adverse effect of SR in
this early phase OA model.
Methods
Animal handling
All experiments were approved by the University’s
Animal Care and Use Committee. Thirty-six 3 month-
old male specific-pathogen free grade Dunkin Hartley
(DH) albino guinea pigs (Vital River Experimental
Animal Technical Co., Ltd., China) were housed in
pairs and given one week to acclimate to the housing
facility. At the start of the experiments, animals
weighed 736 ± 65 g (mean ± SD). Environmental con-
ditions were 25 °C ± 1 °C, humidity 55% ± 10%, with a
12:12 light: dark cycle with lights on at 07:00 and off
at 19:00. Animals were housed in 545 × 380 × 200 mm
cages and given access to a sterilized diet (60Co Guinea
Pig Diet 3035, Beijing HFK Bioscience Co., Ltd., China)
and water ad libitum. Environmental enrichment was four
handfuls of sterilized sawdust nesting material. During
housing, animals were monitored once daily for health
and environmental maintenance. No adverse events
were observed.
Animals were randomly divided into three groups as
follows: Sham group, MNX +V, and MNX + SR groups,
twelve animals per group. Each group was then ran-
domly divided into two subgroups for macroscopic
scoring/micro CT testing (n = 6) or histological scoring/
immunohistochemistry assays (n = 6). Animals were anes-
thetized with sodium pentobarbital (30 mg/kg, ip), and a
medial meniscectomy was performed on the right knee to
create MNX+V, and MNX+ SR groups according to a
protocol described by Bendele [19]. A sham operation
consisting of only an incision in the skin at the same loca-
tion was performed on sham animals. Animals were all
carefully handled and kept warm during and after surgery.
Drug administration was initiated one week after surgery.
The animals in MNX+ SR group received Osseor (Servier,
Co., France) by oral gavage at a dosage of 625 mg/kg daily
at 9:00 AM. Normal saline was given to MNX+V group
as a placebo control and treatment lasted for 12 weeks.
Body weights did not differ among groups by the end of
the experiment. All animals were euthanized by intra-
peritoneal overdose injection of sodium pentobarbital,
blood and operated knee joints were harvested. All
reasonable efforts were made to minimize pain and
suffering. No surgery failed and no animals died during
the experiment.
Specimen processing and OARSI scoring
Primary outcomes were defined using Osteoarthritis
Research Society International (OARSI) scores, and
other results were designated as secondary outcomes.
All samples for macroscopic scoring were sequentially
handled according to our previous research [20]. The
gross appearances were documented by a digital camera
(Canon 550D, Canon, Japan) for evaluating the stage of
the disease according to OARSI macroscopic scoring
system in a blinded fashion [21]. Specimens were then
processed for micro-Computed Tomographic (micro-
CT) assessment.
All samples used for histological assessment were also
handled according to our previous research to produce 8
μm coronal knee sections [20]. Three non-consecutive
toluidine blue stained sections from each sample were
analyzed under an optical microscope (40×, Olympus
BX53, Olympus, Japan) for semi-quantitative OARSI
microscopic scoring [21].
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Considering osteophytes formed on the edge of guinea
pig joints consist both cartilaginous tissue and bony tis-
sue, osteophytes were measured as indicted in Fig. 1. A
line reference was drawn from the medial intercondylar
eminence to the lower corner of the epiphyseal cancel-
lous bone for each sample (L1 or L2). Then, the distance
between the outer upper edge of the osteophyte (P1 or
P2) and the reference line for the operated knee (D1)
and the non-operated knee (D2) was measured. Finally,
osteophytes represented by differences in the distances
between both knees from the same animal (D1-D2) were
noted. Additionally, a collapsed osteophyte could be
seen in Fig. 1, which was defined by disruption of con-
tinuity and hollow space in cartilaginous tissue on the
edge of tibial plateau. Scoring and measurements were
performed in a blinded fashion and averages of the three
sections were representative data.
Subchondral bone microstructure measurement
Proximal tibiae were scanned using a micro-CT system
(ZKKS-Sharp-MCT, Guangzhou, China) to quantify the
micro-architecture of the subchondral trabecular bone, and
the volume of interest (VOI) was defined as the epiphyseal
cancellous bone region 0.5 mm beneath the subchondral
plate of medial tibiae, with voxel size of 20 μm. The peak
X-ray tube potential was 40 kVp and its intensity was 250
mA, respectively. Bone mass and structural characteristics
of VOI were described using bone mineral density (BMD),
bone volume fraction (BV/TV), trabecular number (Tb.N),
trabecular spacing (Tb.Sp), trabecular thickness (Tb.Th),
structure model index (SMI), and degree of anisotropy
(DA). All data were calculated using software designed for
the machine.
Immunohistochemical assessment
For further investigation of cartilage status, aggrecan
(AGG), collagen-II (Col-II), caspase-3, a disintegrin
and metalloproteinase with thrombospondin motifs 4
(ADAMTS-4), and metalloproteinase-13 (MMP-13) were
detected using immunohistochemistry. Paraffin sections
were deparaffinized, rehydrated, and subjected to routine
antigen retrieval using 0.05% trypsin at 37 °C for 30 min,
and endogenous peroxidase activity was suppressed
by 0.3% H2O2 for 15 min, then incubated overnight
at 4 °C with the following antibodies: aggrecan
(1:200) (PAB908Ra02, Cloud-Clone Corp., U.S.),
ADAMTS-4 (1:200) (ab185722, Abcam Inc., U.S.),
Caspase-3 (1:200) (PAA626Ra01, Cloud-Clone Corp.,
U.S.), Col-II (1:50) (II-II6B3 was deposited to the
DSHB by Linsenmayer, T.F.), and MMP-13 (1:200)
(PAA099Ra01, Cloud-Clone Corp., U.S.), respectively.
Other procedures were performed according to
instructions provided with the respective PV-6001
Polink-1 HRP DAB Detection System (ZSGB-BIO
Corp., China) and ZLI-9017 DAB kit (ZSGB-BIO
Corp., China). Sections were counterstained using
Harris’ hematoxylin solution (BASO Diagnostics Inc.,
China) for 30 sec and target protein measurements
in cartilage tissue of the tibial plateau was evaluated
by the average intensity of optical density. The aver-
age intensity of optical density, given in IOD/mm2,
was defined as the sum of integrated option density
divided by area of cartilage tissue in the ROI under
a magnification of 100×. The ROI was defined as the med-
ial tibial plateau cartilage that was 0.5 mm from the medial
intercondylar eminence. These procedures were performed
using Image-Pro Plus (Media Cybernetics, Inc., U.S.).
Statistical analysis
All data are expressed as means with 95% confidence
intervals and categorical data were analyzed using a Chi-
square test with the Fisher’s exact test. A Kolmogorov-
Smirnov test was used to confirm whether distribution
of numerical data fulfilled Gaussian distribution. Com-
parisons of Gaussian distributed measurements between
groups were tested using ANOVA. Fisher’s least signifi-
cant difference t-test or Dunnett’s T3 test was used to
compare any two groups, based on homogeneity of
variance. A Kruskal-Wallis H test was used to analyze
OARSI scores and non-Gaussian distributed data, then a
Mann-Whitney U test was used to compare all pairs of
groups. Two-tailed values of P < 0.05 were considered
statistically significant. All statistical analyses were
processed using SPSS software (SPSS 17.0, SPSS Inc.;
Chicago, IL, U.S.).
Fig. 1 Methods for measuring osteophytes on medial tibial plateau of
both sides of knee. Notes: The blue line (L1 or L2) is the line reference
drawn from the medial intercondylar eminence to the lower corner of
the epiphyseal cancellous bone. The distance between the outer
upper edge of the osteophyte (P1 or P2) and the reference line was
indicated by the red line (D1 or D2). The bar represents length of 1mm
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Results
OARSI scoring of cartilage
The induction of OA significantly impaired articular cartil-
age of the medial tibial plateau which become rougher and
thinner than that in the sham group, with clefts and chon-
dral hyperplasia on the medial edge of the cartilage (Fig. 2).
Five MNX+ SR samples had collapsed osteophytes, and
one sample was similar to this in the MNX+V group, but
there were no significant differences between the MNX+
SR and MNX+V groups (P = 0.080). These results and
OARSI macroscopic scores indicated that joints operated
on had higher scores than sham-operated joints but there
were no significant differences in macroscopic scores
between MNX+ SR and MNX+V groups (P = 0.523).
Histological data for cartilage in the medial tibial
plateau also indicated that cartilage in the load bearing
area of the MNX + V group was severely injured (Fig. 3),
with loss of cartilage or clefts extending to calcified
cartilage, as evidenced by decreased toluidine blue staining
in middle and deeper zones, the formation of cellular clus-
ters, and large chondral hyperplasia on the medial joint
edge with osteophytes underlying it. Total scores for the
MNX+V or MNX+ SR groups were significantly higher
than for shams but there were no significant differences
between MNX+ SR and MNX+V groups (P = 0.297). The
results showed significantly reduction of cartilage thickness
in MNX groups versus sham group (Fig. 2f). Data indicate
(Table 1) that SR increased osteophyte sizes compared to
those in the MNX+V group (P = 0.014). Two MNX+ SR
samples had collapsed osteophytes, and no osteophytes
collapsed in the MNX+V group, so there was no signifi-
cant difference between the MNX+ SR and MNX+V
groups (P = 0.455).
Seven samples had collapsed osteophytes from all twelve
animals in the MNX+ SR group but only one sample was
collapsed in MNX+V group. There was a statistical differ-
ence between SR-treated animals and MNX-operated
saline-treated animals (P = 0.027), and the risk ratio for
osteophyte collapse in the MNX+ SR group was 7.00
[1.01, 48.54].
Immunohistochemical analysis
The expressions of AGG, Col-II, ADAMTS-4, MMP-13,
and caspase-3 protein in the tibial plateau were measured
and Fig. 4 shows that AGG expression in MNX+V and
MNX+ SR groups was significantly lower than those in
sham-operated animals but MMP-13 expression was greater
than that in the sham animals. ADAMTS-4 and caspase-3
were significantly higher in the MNX+V group and there
were no significant differences in expression of colla-
gen type II among the three groups (P = 0.553).
Immunohistochemistry indicated that extracellular
matrix components AGG and Col-II were absent in
chondrocytes in the center of collapsed osteophytes,
whereas positively stained chondrocytes of apoptosis
related protein caspase-3 and degenerative proteins
ADAMTS4 and MMP-13 were observed (Fig. 5). For
un-collapsed samples, an absence of positively stained
Fig. 2 Macroscopic view of right tibial plateau of samples and OARSI macroscopic scoring between groups. Notes: Sham group: (a); MNX + V group:
(b); MNX + SR group: (c); OARSI macroscopic scores between groups (d); OARSI histological scores between groups (e); The results of cartilage
thickness (f). Black arrow indicate cartilage leisions, black arrow head indicate clefts on cartilage, white arrows indicate chondral hyperplasia
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chondrocytes of AGG and Col-II were also observed
in the superficial layer of the transitional area between
the tibial plateau and osteophyte, whereas caspase-3,
ADAMTS4 and MMP-13 positively stained chondro-
cytes were observed. Alignments of chondrocytes were
diffused radially from the base to the surface of cartil-
age at the transitional place between osteophyte and
plateau cartilage.
Micro-architecture parameters of subchondral bone
Figures 6 and 7 show significantly less BMD in the
MNX+V group compared to shams (p = 0.002). However,
BMD was significantly greater in the MNX + SR group
(p = 0.001). Other subchondral bone micro-architecture
parameters (BV/TV, TB.Sp, Tb.Th, and SMI) indicated
subchondral bone loss in the MNX + V group compare
to shams. However, Tb.N (P = 0.404) and DA (P = 0.368)
were not different among groups. Condensed bone tissue
was noted in the sample of collapsed osteophytes.
Discussion
In this study, although subchondral bone was signifi-
cantly enhanced by SR (625 mg/kg/day), it did not
protect cartilage at this dose from degeneration in
meniscectomized guinea pigs. Besides, SR stimulated
osteophytes overgrowth with cleft formation and/or
osteophyte collapse in meniscectomized guinea pigs.
The dose used in this study, considering strontium
bioavailability would be reduced by ~60–70% if taken
with calcium or food, is similar to that used by Pelletier et
al. [15]. They demonstrated therapeutic effects of 75 mg/
kg/day in ACLT dogs at least 2 h before feeding. Yu et al.
[16] reported that 1,800 mg/kg/day showed therapeutic ef-
fects in MNX rats. Bruel et al. [22] showed that mean
serum Sr of 8990 μg/L results from 8 weeks of 900 mg/
kg/day for rats, thus serum Sr in Yu’s study should be no
less than this value. On the contrary, Meunier et al. [23]
reported the mean serum Sr is 117.9 μg/L in patients
who regularly receive SR at 2 g/day. Because a potential
risk of venous thromboembolism (VTE) may occur in
SR-treated patients [24], high SR dose may encounter
obstacles when adapting the drug to human OA treat-
ment. In this view, a lower dose as in this study and
Pelletier et al.’s tends to be more appropriate.
Although several in vivo studies are described in the
literature [15, 16], none have focused on SR in a
guinea pig model which has been described by Bendele
in detail [19]. This model is similar to human OA, and
features cartilage degeneration, osteophytes formation,
and fibroblast proliferation in the synovium. Surgically
induced OA models, such as anterior cruciate liga-
ment transectomized (ACLT) [25] and MNX animals,
generate cartilaginous lesions rapidly but different
surgical approaches cause various rates of cartilage
degeneration. Generally, cartilage in the MNX model
degenerates more rapidly than in the ACLT model due
to more joint instability [19]. Thus, the MNX model
might narrow the therapeutic window for drug inter-
vention. And they might be obscured if there exist
any potential therapeutic effects of SR.
Table 1 Osteophyte measurements and collapsed osteophytes
Group D1 (n = 6, μm) D2 (n = 6, μm) Osteophyte size
(D1-D2, n = 6, μm)
Collapsed osteophytes
in macroscopic
samples (n = 6)
in histologic
samples (n = 6)
in all samples
(n = 12)
Sham 263.62 [231.18, 296.06] 280.26 [247.42, 313.10] -16.64 [-39.56, 6.28] 0 0 0
MNX + V 370.19 [330.19, 410.19]* 263.33 [234.28, 292.39] 106.86 [46.93, 166.79]* 1 0 1
MNX + SR 445.97 [415.36, 476.58]*† 247.79 [212.40, 283.17] 198.18 [147.48, 248.88]*† 5 2 7*†
* vs. Sham group, P < 0.05
† vs. MNX + V group, P < 0.05
Fig. 3 OARSI Microscopic scoring among groups. Notes: Toluidine
blue stain of medial tibial plateau of samples, 40×. Sham group: (a)
for left knee and (b) for Right knee; MNX + V group: (c) for left knee
and (d) for right knee; MNX + SR group: (e) for left knee and (f) for
right knee. Bars represent length of 1 mm
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Instead, SR stimulated osteophyte growth and subse-
quent collapse. The method of osteophyte measurement
is adapted from the method for rats reported by Gerwin
et al. which only measured cartilaginous tissue [26].
Osteophytes often grow upward and outward on tibial
plateau edge and guinea pigs’ osteophytes contain more
bony tissue, so data from this method should be more
representative with respect to the extent of osteophytes
growth direction. Our data show that osteophytes were
larger in SR-treated animals, which indicates that osteo-
phytes may be stimulated by SR. This finding is sup-
ported by work published by Panahifar et al. [6] who
used SR as a tracer and mapped strontium with electron
probe microanalysis (EPMA). They reported strontium
incorporated toward the osteophytic margins in menis-
cectomized rats. Panahifar et al. further reported that
strontium was heavily incorporated in mineralizing
osteophytes at 4, 8, and 12 weeks post-surgery, whereas
it was incorporated in subchondral bone only between
weeks 8-12 [18]. However, an earlier study in which
radioactive strontium isotope 85Sr was used as a tracer
for monitoring patella bone turnover in the medial or
lateral femorotibial articulation in severe symptomatic
OA patients [27], suggesting that osteophytes were not
associated with high uptake of 85Sr. These contradictory
data may be explained by different phases of OA pro-
gression aimed in these studies. Panahifar et al. sug-
gested that in early phases of OA progression, rather
than the knee plateau, osteophytes have greater affinity
for strontium. Furthermore, SR can strongly stimulate
human cartilage matrix formation in vitro by a direct
ionic effect [28]. From strontium accumulation, chon-
drocytes in osteophytes could be specifically stimulated
and the chondral aspect of the osteophyte grows, form-
ing larger osteophytes in early OA. Chondrocytes in the
knee plateau were merely stimulated, thus cartilage
degeneration may be unaffected.
Collapsed osteophytes observed here were related to
condensed subchondral bone beneath the osteophyte,
not only related to osteophyte overgrowth stimulated by
Fig. 4 Immunohistochemical staining of load bearing zone of tibial plateau of groups. Notes: 100×, bars represent a length of 400 μm
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SR. Figures 3f and 6c show that canals almost disappeared
in bony osteophytes and the subchondral bone plate. Con-
densed subchondral bone could transmit increased loads to
overlying cartilage, although its reason is unclear, leading to
further cartilage degeneration [29]. In contrast, because the
articular cartilage is avascular, the permeability of calcified
cartilage and subchondral bone plates allows crossover
communication, providing connecting channels between
subchondral bone and cartilage [30]. Canal reduction in
subchondral bone or osteophytes would affect nutrition
and oxygen and induce chondrocyte apoptosis, which could
contribute to osteophyte collapse.
It was noted that chondrocytes alignments diffused
radially from the cartilage-subchondral bone interface to
the cartilage surface at the transitional area between
plateau and osteophyte. This suggests that this region is
under abnormal mechanical stress, which may be due to
stretching by osteophyte and plateau cartilage. This
transverse force may be derived from the bearing load
and transduced by excessively grown osteophytes. Then,
this region would have exhibits catabolic changes. AGG
and Col-II, two major components of the cartilage
matrix [31, 32], were absent in chondrocytes located in
the center of collapsed osteophytes, and this may sus-
pend the repair process. Also, ADAMTS4 and MMP-13,
enzymes responsible for degrading AGG and Col-II
[33, 34], were expressed by chondrocytes, which will
accelerate cartilage degeneration locally. These findings
were supported by Su et al. [35] who reported that an
in vitro model mimics mechanical stress and undergoes
similar changes in chondrocytes. Abnormal mechanical
stress can also induce chondrocyte apoptosis, which
was shown by increased expression of caspase-3 which
is associated with mechanical stress according to Kong
et al. [36]. Thus, these changes contribute to the for-
mation of a cleft in the region between the osteophyte
and the knee plateau.
The limitation of the current study include the small
number of animals and the single time point. To avoid
diffused staining in immunohistochemistry procedure
caused by 100% ethanol fixation, we had to randomly
divide each group further into two subgroup. Conse-
quently, the number of animals available for microCT
and immunohistochemistry analysis were reduced.
Another consequence is randomization could not com-
pletely eliminate sampling error between subgroups,
which result in potential weaken the power of results.
The study conducted on a surgical induced OA model,
the progress of cartilage lesion is rapid. Single time
Fig. 6 Reconstruction of coronal section of right tibial plateau from each group. Notes: Sham group: (a); MNX + V group: (b); MNX + SR group
with collapsed osteophyte: (c); MNX + SR group with un-collapsed osteophyte: (d)
Fig. 5 Immunohistochemical staining of cartilage at the transitional
place between osteophyte and plateau cartilage. Notes: 100×, bars
represent a length of 400 μm
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point observation may be insufficient to discover po-
tentially existed therapeutic effect of SR. And the last,
the secondary outcomes, such as osteophyte over-
growth and osteophyte collapse, should be tested and
verified by further research.
Conclusions
In conclusion, SR (625 mg/kg/day) did not protect
cartilage from degeneration in an MNX guinea pig
model but subchondral bone was significantly enhanced
by SR treatment. In this early phase OA model, SR causes
osteophyte overgrowth and this may be due to its ability
to incorporate into osteophytes and promote hyperplasia.
This adverse effect should be monitored in future SR
studies of OA.
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